CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $94.10, but opened at $88.60. CochLear shares last traded at $88.60, with a volume of 1,795 shares.
Analyst Upgrades and Downgrades
A number of analysts recently commented on CHEOY shares. Canaccord Genuity Group raised CochLear from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 7th. Citigroup lowered CochLear to a “neutral” rating in a research report on Thursday, September 18th. Finally, Zacks Research raised shares of CochLear to a “hold” rating in a report on Monday, August 11th. Two research analysts have rated the stock with a Strong Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, CochLear has a consensus rating of “Moderate Buy”.
View Our Latest Research Report on CochLear
CochLear Trading Down 4.3%
CochLear Announces Dividend
The business also recently announced a dividend, which was paid on Tuesday, October 28th. Shareholders of record on Monday, September 22nd were paid a $0.1045 dividend. The ex-dividend date was Friday, September 19th. This represents a yield of 122.0%.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than CochLear
- Why Invest in 5G? How to Invest in 5G Stocks
- 4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive
- What is an Earnings Surprise?
- Oklo’s Meltdown Is Over: A Robust Rebound Lies Ahead
- What Makes a Stock a Good Dividend Stock?
- 3 Reasons On Holding’s Sell-Off Is Over and New Highs Are Coming
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
